About PURE MHC LLC
Pure MHC is a discovery and development company specializing in HLA-based target identification and validation for therapeutic development in oncology, autoimmunity, and infectious diseases. The company provides contract research services leveraging its proprietary soluble HLA proteins and extensive HLA expertise.
HLA Class I and Class II target identification and validationImmunotherapeutic drug development for cancer, infectious, and autoimmune diseasesEpitope validation, development, and therapeutic exploitationMass spectrometry, proteomics, peptidomics, and informaticsTissue culture, epitope screening validation, peptide binding, and HLA extractionTransfection, production, and purification of proprietary soluble HLA proteinsAnalysis of small primary tumor and healthy tissue samples
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PURE MHC LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.